Form 4 for AGL agilon health, inc.
Accepted 2022-04-20 00:00:00 ET · period of report 2022-04-14 · accession 0001209191-22-025015 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-04-20 | 2022-04-14 | AGL | Mansukani Sharad | Dir | A - Grant | $0.00 | +6,936 | 1.24M | +0.6% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-14 | A | A | 6,936 | $0.00 | 1,236,292 | D | — | — | (F1) Restricted stock units that vest in full on April 14, 2023, subject to continued service as a director. (F2) Includes restricted stock units. |